Web Results


A class action against Boiron, filed in 2011 on behalf of "all California residents who purchased Oscillo at any time within the past four years", charged that Boiron "falsely advertises that Oscillo has the ability to cure the flu because it contains an active ingredient it claims is proven to get rid of flu symptoms in 48 hours.


Oscillococcinum (or Oscillo) is a homeopathic preparation marketed to relieve influenza-like symptoms. It does not provide any benefit beyond that of sugar pills . It is a popular preparation, particularly in France. It is manufactured by Boiron, its sole manufacturer. Oscillococcinum is used in more than 50 countries and has ...


Jan 19, 2018 ... Organon USA, Inc., et al., No. 10-P-233; No. BER-L-2831-09. Ohio. Rodgers et al. v. Southwestern Energy Company, et al., No.: 5:16-cv-00054-JPB. Ohio. Mazzei v . Professional Land Resources, LLC, et al., No. 15-C-193. Preston. Bank Of America, N.A. v. Brown, No. 15-C-681-B. Raleigh. Boggs v.


Aug 29, 2017 ... 15-C-149. Nanack v. Organon USA, Inc. et al., No. 10-P-233; No. BER-L-2831-09 . RQdgers et al. v. Southwestern Energy Company, et al., No. 5:16-cv-00054-JPB. Zaken, et al. v. Charles, et al., No. 13-C-317. Bank Of America, N.A. v. Brown, No. 15-C-681-B. Boggs v. FIA Card Services, N. A., No. 13-C-834- ...


Aug 24, 2016 ... Omnicare is represented by C. Thomas Brown, Brien O'Connor and Aaron Katz of Ropes & Gray, and Harvey Kurzweil, Suzanne Jaffe Bloom and Benjamin Sokoly of Winston & Strawn LLP. The case is United States ex rel. Richard Templin and James Banigan et al v. Organon USA Inc. et al., case number ...


CIVIL ACTION NO. 07-12153-RWZ. UNITED STATES OF AMERICA, ex rel. JAMES BANIGAN and RICHARD TEMPLIN, et al. v. ORGANON USA INC., et al. ORDER. August 23, 2016. ZOBEL, J. Before the court are two motions for summary judgment filed by Omnicare, Inc., a long-term care pharmacy. The first ( Docket ...


Jun 29, 2016 ... Omnicare Inc. engaged in a perfectly legal drug discount program that was studiously noted in written agreements, the company told a Massachusetts federal judge Wednesday as it ... et al v. Organon USA Inc. et al., case number 1: 07-cv-12153-RWZ in the U.S District Court for the district of Massachusetts


for Negative Selection of' Mouse T Cell Receptor V~ .... separation medium (LSM) (Organon Technica, Kensington, MD) .... 149 Ildstad et al. (6-17). We have now examined the staining profile of mouse- derived lymphoid ceils in the thymus and spleen of mixed xenogeneic chimeras to determine whether the developmen-.


ML-glutamine (Life Technologies, Inc.: DC medium). The cells were cultured with the recombinant human cytokines GM-CSF (500 units/ml;. Schering-Plough,. Kenilworth. NJ). ... more detail elsewhere (R.A.Henderson et ai. manuscript in preparation). CD34+ Cell ... ton Dickinson) were used in all experiments. Briefly, cells ...